Home
About Us
Group Introduction
Founder Introduction
Global Cooperation
Nanolattix Biotechnology
Company Profile
Development History
Research Layout
Nanolattix Health
Extraction Platform
Cosmetics
Machine
Food Brand
Disinfection
Oem/Odm
News
Company News
Industry News
Contact Us
简体中文
English
Release time:
2025-01-10
U.S. FDA Grants Orphan Drug Designation to Nanolattix T320 for Pancreatic Cancer Treatment
Tag:
Previous Page
2024.9
2024.4
Next Page
Previous Page:
Next page:
recommend News
Enhancing the original innovation capability of the biopharmaceutical industry
2024-09-03
The biomedicine and health industry is an important breakthrough point for cultivating new quality productivity.
Reform Dynamics | Biomedicine and Health
Shanxi Nanolattix Biotechnology Co., Ltd. is a high-tech enterprise focused on biomedicine and technological plant extracts.
There is no path in life that is walked in vain; every step counts.
2024-08-16
Share
